SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

25 Apr 2022 Evaluate
A slight decline in the revenue of Rs. 1018.80 millions was seen for the March 2022 quarter as against Rs. 1044.97 millions during year-ago period.Net profit declined -7.20% to Rs. 188.87 millions from Rs. 203.53 millions.Operating Profit reported a sharp decline to 232.91 millions from 260.46 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1018.80 1044.97 -2.50 4278.11 2911.88 46.92 4278.11 2911.88 46.92
Other Income 11.88 20.10 -40.90 105.06 50.98 106.08 105.06 50.98 106.08
PBIDT 232.91 260.46 -10.58 1162.77 702.85 65.44 1162.77 702.85 65.44
Interest 11.81 10.45 13.01 48.32 42.07 14.86 48.32 42.07 14.86
PBDT 221.10 250.01 -11.56 1114.45 660.78 68.66 1114.45 660.78 68.66
Depreciation 21.47 17.75 20.96 81.80 67.30 21.55 81.80 67.30 21.55
PBT 199.63 232.26 -14.05 1032.65 593.48 74.00 1032.65 593.48 74.00
TAX 10.76 28.73 -62.55 72.79 79.89 -8.89 72.79 79.89 -8.89
Deferred Tax -24.23 -11.94 102.93 -107.29 -23.77 351.37 -107.29 -23.77 351.37
PAT 188.87 203.53 -7.20 959.86 513.59 86.89 959.86 513.59 86.89
Equity 221.65 200.88 10.34 221.65 200.88 10.34 221.65 200.88 10.34
PBIDTM(%) 22.86 24.93 -8.28 27.18 24.14 12.60 27.18 24.14 12.60

Tatva Chintan Pharma Share Price

1275.10 0.00 (0.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×